Cook Medical Announces The North American Launch Of Advance(R) 18LP PTA Balloon Dilatation Catheter

Main Category: Medical Devices / Diagnostics
Also Included In: Cardiovascular / Cardiology
Article Date: 21 Oct 2008 - 6:00 PDT

email to a friend   printer friendly   opinions  

As part of an ongoing effort to expand its comprehensive offering of diagnostic and interventional devices, Cook Medical announced today the North American launch of its Advance® 18LP Balloon Dilatation Catheter. With a low crossing profile and small sheath compatibility, Advance 18LP is designed to provide physicians with superior deliverability.

Cook's Advance 18LP is a .018" wireguide compatible PTA balloon intended for use in patients with lesions of the peripheral arteries (including the iliac, renal, popliteal, infrapopliteal, femoral and iliofemoral), as well as obstructive lesions of native or synthetic arterio-venous dialysis fistulae. The new catheter will be an integral part of Cook's Advance PTA balloon line and will play a major role in Cook's leg therapies program.

"The Advance 18LP is the first of several new PTA balloons that Cook is developing specifically for leg therapies," said Rob Lyles, global leader of Cook Medical's peripheral intervention business unit. "The Advance 18LP has been evaluated by over 50 physicians globally and we are extremely excited about the positive feedback, especially relating to the low profile and rapid deflation time."

With 4 Fr sheath compatibility through 7 mm diameters, Advance 18LP has the smallest sheath compatibility of any .018" compatible balloon currently available in North America. The device utilizes advanced thermal setting of the balloon folds for improved rewrap and sheath pull-back. A unique double-lumen shaft construction using optimized nylon-blend material reduces balloon inflation/deflation time and improves pushability while maintaining kink resistance.

About Cook Medical

Cook Medical was one of the first companies to help popularize interventional medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates minimally invasive medical device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Founded in 1963 and operated as a family-held private corporation, Cook is a past winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine.

Source
David McCarty
Cook Medical

• Additional
• References
• Citations